Somatic gene transfer to salivary glands

Annals of the New York Academy of Sciences

Volumn 842, Issue , 1998, Pages 171-180

  O'Connell, Brian C ^a   Lillibridge, C David ^a   Ambudkar, Indu ^a   Kruse, David ^b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; CELL REGENERATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; IMMUNOGENICITY; MITOSIS; NONHUMAN; RADIATION INJURY; SALIVARY GLAND DISEASE; SALIVATION; SUBMANDIBULAR GLAND; TRANSGENIC ANIMAL;

EID: 0031970689     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09645.x     Document Type: Conference Paper

References (42)

1. Ross, G., R. ERICKSON, D. KNORR et al 1996. Gene therapy in the United States: a five-year status report. Hum. Gene Ther. 7: 1781-1790.
2. MARCEL, T. & J.D. GRAUSZ. 1996, The TMC Worldwide Gene Therapy Enrollment Report (June 1996). Hum. Gene Ther. 7: 2025-2046.
3. LEIDEN, J.M. 1995. Gene therapy - promise, pitfalls, and prognosis [editorial; comment]. N. Engl. J. Med. 333: 871-873.
4. TOUCHETTE, N. 1996. Gene therapy: Not ready for prime time. Nature Med. 2: 7-8.
5. FLOTTE, T.R. & T.W. FERKOL. 1997. Genetic therapy. Past, present, and future. Pediatr. Clin. North Am. 44: 153-178.
6. LEDLEY, F.D. 1996. "Our study is man" (and woman) [editorial]. Hum. Gene Ther. 7: 1193-1195.
7. ROHLMANN, A., M. GOTTHARDT, T.E. WILLNOW, R.E. HAMMER & J. HERZ. 1996. Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat. Biotechnol. 14: 1562-1565.
8. COLLINS, F.S. 1997. Sequencing the human genome. Hosp. Pract. 32: 35-43,46-39, 53-34.
9. TSUKUI, T., Y. KANEGAE, I. SAITO & Y. TOYODA. 1996. Transgenesis by adenovirus-mediated gene transfer into mouse zona-free eggs. Nat. Biotechnol. 14: 982-985.
10. WILSON, J.M. 1996. Animal models of human disease for gene therapy. J. Clin. Invest. 97: 1138-1141.
11. KAPLAN, J.M., D. ARMENTANO, T.E. SPARER et al. 1997. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum. Gene Ther. 8: 45-56.
12. YANG, Y., Q. Li, H.C. ERTL & J.M. WILSON. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 69: 2004-2015.
13. WORGALL, S., G. WOLFF, E. PALCK-PEDERSEN & R.G. CRYSTAL. 1997. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8: 37-44.
14. GILGENKRANTZ, H., D. DUBOC, V. JUILLARD et al 1995. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum. Gene Ther. 6: 1265-1274.
15. SMITH, T.A.G., B.D. WHITE, J.M. GARDNER, M. KALEKO & A. MCCLELLAND. 1996. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther. 3: 496-502.
16. TRIPATHY, S.K., H.B. BLACK, E. GOLDWASSER & J.M. LEIDEN. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2: 545-550.
17. YANG, Y., K. GREENOUOH & J.M. WILSON. 1996. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Then 3: 412-420.
18. SIMON, R.H., J.F. ENGELHARDT, Y. YANG et al. 1993. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum. Gene Then 4: 771-780.
19. OHNO, T., D. GORDON, H. SAN et al. 1994. Gene therapy for vascular smooth muscle cell proliferation after arterial injury [see comments]. Science 265: 781-784.
20. KOZARSKY, K.F., D.R. MCKINLEY, L.L. AUSTIN et al. 1994. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269: 13695-13702.
21. MORSY, M.A., J.Z. ZHAO, T.T. NGO et al. 1996. Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes. J. Clin. Invest. 97: 826-832.
22. KESSLER, D.A., J.P. SIEGEL, P.D. NOGUCHI et al. 1993. Regulation of somatic-cell therapy and gene therapy by the food and drug administration. N. Engl. J. Med. 329: 1169-1173.
23. RIVERA, V.M., T. CLACKSON, S. NATESAN et al. 1996. A humanized system for pharmacologic control of gene expression. Nature Med. 2: 1028-1032.
24. MASTRANGELI, A., B. O'CONNELL, W. ALADIB et al. 1994. Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am. J. Physiol. 266: G1146-G1155.
25. BARKA, T. & H.M. VAN DER NOEN. 1996. Retrovirus-mediated gene transfer into salivary glands in vivo. Hum. Gene Ther. 7: 613-618.
26. O'CONNELL, B.C., T. Xu, T.J. WALSH et al. 1996. Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands. Hum. Gene Ther. 7: 225-2261.
27. DELPORTE, C., B.C. O'CONNELL, X. HE et al. 1997. Increased fluid secretion after adenoviralmediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc. Natl. Acad. Sci. USA. 94: 3268-3273.
28. FRANZEN, L., U. FUNEGARD, T. ERICSON & R. HENRIKSSON. 1992. Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort. Eur. J. Cancer. 28: 457-462.
29. PRICE, R.E., K.K. ANG, L.C. STEPHENS &L.J. PETERS. 1995. Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys. Radiother. Oncol. 34: 39-46.
30. BAUM, B.J. & B.C. O'CONNELL. 1995. The impact of gene therapy on dentistry. J. Am. Dent. Assoc. 126: 179-189.
31. DELPORTE, C., B.C. O'CONNELL, X. HE et al. 1996. Adenovirus-mediated expression of aquaporin-5 in epithelial cells. J. Biol. Chem. 271: 22070-22075.
32. BECKER, T.C., R.J. NOEL, W.S. COATS et al. 1994. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43 Pt A: 161-189.
33. KAGAMI, H., B.C. O'CONNELL & B.J. BAUM. 1996. Evidence for the systemic delivery of a transgene product from salivary glands. Hum. Gene Ther. 7: 2177-2184.
34. ADESANYA, M.R., R.S. REDMAN, B.J. BAUM & B.C. O'CONNELL. 1996. Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. Hum. Gene Ther. 7: 1085-1093.
35. JOHNSON, D.G., J.K. SCHWARZ, W.D. CRESS & J.R. NEVINS. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365: 349-352.
36. SCHWARZ, J.K., C.H. BASSING, I. KOVESDI et al. 1995. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc. Natl. Acad. Sci. U S A 92: 483-487.
37. LILLBRIDGE, C.D. & B.C. O'CONNELL. 1997. In human salivary gland cells, overexpression I of E2F1 overcomes an interferon-γ and tumor necrosis factor-α induced growth arrest but does not result in complete mitosis. In press.
38. YAMASAKI, L., T. JACKS, R. BRONSON, et al 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537-548.
39. KOWALIK, T.F., J. DEGREGORI, J.K. SCHWARZ & J.R. NEVINS. 1995. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69: 2491-2500.
40. COTTEN, M. 1995. Adenovirus-augmented, receptor-mediated gene delivery and some solutions to the common toxicity problems. Curr. Top. Microbiol. Immunol. 199: 283-295.
41. DOUGLAS, J.T., B.E. ROGERS, M.E. ROSENFELD, et al. 1996. Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol. 14: 1574-1578.
42. WICKHAM, T.J., P.YV. ROELVINK, D.E. BROUGH & I. KOVESDI. 1996. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell layers. Nat. Biotechnol. 14: 1570-1573.